Health newsRecent Post

COVID-19: AstraZeneca CEO on long-term protection from jab

The boss of pharmaceutical giant AstraZeneca says its coronavirus vaccine – developed with Oxford University – may have played a key role in reducing Covid-related hospitalisations in the UK.

Pascal Soriot said his company’s vaccine promoted a greater T-cell [part of the immune system which defends the body against specific infections] response in older people than some others.

Mr Soriot was speaking to the Today programme ahead of the formal opening of AstraZeneca’s new science lab in Cambridge.

Source link

Comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.